AXREM Announces Candice Martin as Vice Convenor of the Radiotherapy Special Focus Group

19 May 2026

AXREM is pleased to announce the appointment of Candice Martin as Vice Convenor of the AXREM Radiotherapy Special Focus Group (SFG). 

Candice is Commercial Director at Amethyst Radiotherapy, operating at board level and leading commercial strategy, growth, and market expansion across the UK. 

She has a proven track record of securing high-value contracts, scaling radiotherapy and diagnostic services, and delivering sustainable EBITDA growth within complex, regulated healthcare environments. 

With a strong blend of commercial and operational expertise, Candice works in close partnership with NHS Trusts, ICBs, and private providers to develop and mobilise high-quality, patient-centred services at pace. 

Candice is known for her strategic focus, negotiation strength, and ability to translate opportunity into measurable results, she leads high-performing teams to deliver both business impact and improved patient outcomes. 

As Vice Convenor of the Radiotherapy SFG, Candice will support the group’s work in bringing together providers, manufacturers, and stakeholders across the radiotherapy community, helping to address shared challenges, promote best practice, and support innovation across the sector. 

Candice said: 

I am delighted to accept the role of Vice Convenor of the AXREM Radiotherapy SFG. I am passionate about the radiotherapy industry and look forward to collaborating with colleagues across the group to support its ongoing work and impact. 

AXREM’s Radiotherapy SFG Convenor, David Kynaston said: 

I am delighted to welcome Candice as Vice Convenor of the Radiotherapy Special Focus Group. Having recently joined the SFG, Candice brings a variety of fresh ideas and a wealth of experience to the team. Her appointment highlights both the diverse range of companies we represent and the progress we are making, all with the same goal, to improve radiotherapy access and treatments for patients nationally. 

AXREM, CEO Sally Edgington said: 

“Candice’s appointment reflects the continued strengthening of our Radiotherapy Special Focus Group and the breadth of expertise our members bring to the table. Her combination of commercial insight, operational experience and deep understanding of the radiotherapy landscape will be a real asset to the group’s work. 

AXREM is committed to supporting a collaborative, forward‑looking radiotherapy community and Candice’s leadership will help us continue driving progress, sharing best practice and championing improvements that ultimately benefit patients across the UK.” 

The AXREM Radiotherapy Special Focus Group (SFG) provides a collaborative forum for organisations involved in the delivery, supply, and support of radiotherapy services across the UK. The Group brings together providers, manufacturers, and sector stakeholders to share insight, address common challenges, and promote best practice. Through collaboration and engagement with the wider healthcare system, the Radiotherapy SFG supports innovation, service sustainability, and the delivery of safe, high‑quality, patient‑centred radiotherapy services. 

For more information about the AXREM Radiotherapy Special Focus Group and its activities, please visit axrem.org.uk/radiotherapy